Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Hyperphosphatemia
Condition: End-Stage Renal Disease Hemodialysis, Serum PO4 greater than 9 mg/dL (2.91 mmol/L)
Dose: Oral Tablet – 1600 mg
Frequency: every 8 hours with meals
Note: Initial dose
Indication: Hyperphosphatemia
Condition: End-Stage Renal Disease Hemodialysis, Serum PO4 7.5-9 mg/dL (2.42-2.91 mmol/L)
Dose: Oral Tablet – 1200-1600 mg
Frequency: every 8 hours with meals
Note: Initial dose

Child Dose

Clinical InformationAdministration Information
Age: Child
Dose: Safety and efficacy not established
Note: Safety and efficacy not established
Administration
  • Take with meals
  • Do not chew tablets
Side Effect

Drug Interaction

Drug NameRisk Factors
Ciprofloxacin, Ciclosporin, Mycophenolate, Tacrolimus, Levothyroxine
May decrease absorption

Disease Interaction

Disease NameRisk Factors
Hypophosphatemia
Can lower phosphate further
Bowel Obstruction
Can worsen blockage

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool and dry place, protected from light.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.